BioAuxilium was founded by Dr. Jaime Padros and Mireille Caron, each have over 20 years of academic and industry experience. They have a renowned expertise in the design, development and manufacturing of assay kits and reagents on the most popular technology platforms available (e.g., TR-FRET, AlphaScreen®/AlphaLISA®, BRET/BRET2, FP, Aequorin and more).
Before BioAuxilium, Mireille and Jaime were Technical Project Leaders and Senior Scientists at PerkinElmer-BioSignal (Montréal), where they played key roles in the development of several commercially successful products based on TR-FRET. Since the inception of BioAuxilium in 2013, Mireille and Jaime, supported by their team of scientists, have developed and licensed hundreds of TR-FRET assay kits enabling the quantification of cellular proteins and biomarkers.
BioVendor cooperates with us only for miRNA sequencing services and the development of specific miRNA qPCR kits.
With their innovative technology, they use two tailed qPCR primers for 100% specific miRNA results.
Using this method the false positive results are reduced to less than 4%.
Please send us your request for this service by e-mail.
Capitainer is developing the next generation of blood cards:
Imagine a future where you wouldn't have to leave your home to provide a blood sample for clinical analysis. A future in which anyone can take a blood sample from themselves at any time and anywhere and send it by mail to the laboratory for analysis. And then you will get a result with higher accuracy than if the sample was taken by trained medical staff in a health center.
That future is now – made possible by state-of-the-art technology from Capitainer.
Our vision: We believe in equal access to health diagnostics for everyone, everywhere!
Our task: We improve health outcomes for all by providing universal precision sampling technologies.
Cellexus is a revolutionary pioneer and market leading in single-use airlift bioreactor systems and technology.
The CellMaker airlift bioreactor is ideal for cell culture and fermentation in various applications including phage production, aerobic and anaerobic fermentation processes, alt. protein production, cellular agriculture, advanced therapeutics, protein expression, viral vector production, fungal biomass, monoclonal antibodies, stem cells and many other bio therapeutics. Our single-use bioreactor has been proven successful with microbial fermentations, such as E. coli expression systems, phage amplification, CHO cell culture and antibody production in both GMP and GLP environments.
Cyanagen is an Italian biotech company founded in Bologna in 2003 and certified ISO9001:2015 and ISO13485:2016.
The Company’s core business is designing, developing and manufacturing DNA/RNA extraction kits, chemiluminescent substrates and fluorescent antibodies. These products can be used in research in life sciences (RUO) and In Vitro Diagnostics (CE-IVD).
Our key technologies, covered by international patents, achieve outstanding sensitivity and stability performance and ease of use. Cyanagen is one of the world’s leading manufacturers of chemiluminescent substrates for Western blotting and ELISA/CLIA.
Our fluorescent antibodies are for biological analysis, cell imaging, genomics, and proteomics.
Invitek is a global provider of molecular diagnostics products
The full spectrum of workflows: from sample to result
Invitek products are designed for ultimate ease of use and time saving, with a modular system that can be adapted to any laboratory environment. With Invitek Diagnostics, you can streamline your processes and work efficiently from sample collection and extraction to detection and point-of-use. Discover our complete portfolio for:
- food testing
- human and veterinary diagnostics
- genetic testing
- microbiome analysis
- oncology
- life sciences
Molecular Biology Systems is home to NextGenPCR™, an Ultra fast PCR thermal cycler delivering the world’s fastest PCR technology. Based on our patented technology Molecular Biology Systems has managed to build the fastest thermal cycler available worldwide. For some fragments our thermal cycler is even able to perform a full 3 temperature, 30 cycle PCR in as little as 2 minutes. Above all, NextGenPCR™ ultrafast thermal cyclers accept 96-well plates as well as 384-well plates seamlessly.
Decrease your energy costs substantially with the ultra fast PCR thermal cycler
The ultra fast PCR thermal cycler is also a much greener solution, using plates that are 3.9 times lighter, which means using less polypropylene and up to 50 times less energy per PCR reaction. The latter means the lab uses less energy to cool the room. Taken together this leads to an energy efficiency that is well over 50 times better comparing to standard thermal cyclers.
NETRI manufactures devices and models using its pilot production units of microfluidic devices and cell culture automated labs. With more than 200 m² of production platform, 3 microfluidics plates are marketed and divided into 3 options.
Five types of neurons human cells derived from stem cells as well as primary keratinocytes and endothelial cells are marketable with our devices. In 2024, with the construction of its production site, NETRI will increase the production capacity of its pre-industrial pilot units.
Novoprotein is a high-tech company with more than 10 years of extensive experience in producing recombinant proteins. We focus our protein technology on research and development, production, sales and application solutions for raw materials and techniques for biopharmaceuticals, in vitro diagnostics, mRNA vaccines and basic research.
Our main products include growth factors and cytokines, recombinant antibodies, molecular enzymes and reagents, as well as the provision of related technical services. Novoprotein has research, development and production sites in Shanghai, Suzhou and Heze.
We have developed more than ten thousand recombinant proteins and independently researched and developed 7 comprehensive technology platforms and 23 core technologies, including protein design, modification, protein production and quality control, and protein application and evaluation.
Scinora offers products without animal ingredients for the proper and consistent transition from animal testing to the New Approach Methodologies (NAMs) and for the efficient production of recombinant proteins.
The focus is on cell culture; the media we develop allows you to cultivate your cells without animal components.
Our expertise includes solutions for toxicological assessment, exosome and biopharmaceutical production and cell culture of spheroids/suspensions, e.g. towards cultured meat or therapeutic approaches.
StressMarq Biosciences is a bioreagents company producing high quality, cutting edge research products for the life sciences and drug discovery/biopharma markets.
StressMarq is a market leader in the development and commercialization of a range of unique fibrilized and oligomeric protein preparations for use in neurodegenerative disease research, including proteins such as alpha synuclein, tau, amyloid beta, SOD1 and TTR. StressMarq’s strategic efforts are focused on expanding the breadth and depth of this product offering to assist researchers studying Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.
In addition to our focus on products for neurodegenerative disease research, our diverse portfolio of antibodies, proteins, kits and small molecules are utilized across a range of life sciences including neuroscience, cancer research and cell signaling.